Millipore Sigma Vibrant Logo
Atención: Nos hemos mudado. Los productos Merck Millipore ya no pueden adquirirse en MerckMillipore.comMás información

ABE1446 Anti-phospho-53BP1 (Thr1609/Ser1618) Antibody

ABE1446
100 µL  
Purchase on Sigma-Aldrich

Ofertas especiales

Descripción

Replacement Information

Ofertas especiales

Tabla espec. clave

Species ReactivityKey ApplicationsHostFormatAntibody Type
HWBRbSerumPolyclonal Antibody
Description
Catalogue NumberABE1446
DescriptionAnti-phospho-53BP1 (Thr1609/Ser1618) Antibody
Alternate Names
  • Tumor suppressor p53-binding protein 1
  • phospho 53BP1 (Thr1609/Ser1618)
  • 53BP1
  • p53-binding protein 1
  • p53BP1
Background InformationTumor suppressor p53-binding protein 1 (also known as 53BP1, p202, p53-binding protein 1, p53BP1) is encoded by the TP53BP1 gene (Entrez Gene ID 7158) in human. 53BP1 is a multidomain nonhomologous end joining (NHEJ) factor involved in the repair of double-strand DNA breaks (DSBs). The minimal region (residues 1,220–1,711) required for its recruitment includes the oligomerization domain, the tudor domain, and a carboxy-terminal extension termed the ubiquitination-dependent recruitment (UDR) motif. However, 53BP1 function must be inactivated during mitosis to prevent its interference with homologous recombination (NR). 53BP1 inactivation during mitosis is shown to be achieved by p38-dependent pT1609 and PLK-1-dependent pT1618 phosphorylation within the UDR motif. Reactivating 53BP1 function results in severe mitotic defects (PMID 24703952 & 24652939). Cat. No. ABE1446, Anti-phospho-53BP1 (Thr1609/Ser1618) is a rabbit polyclonal antiserum raised against human 53BP1-derived phosphopeptide encompassing pT1609/pS1618 phosphorylation site sequence (PMID 24703952) present in all three 53BP1 isoforms (UniProt Q12888). This antiserum recognizes 53BP1 only when both Thr1609/Ser1618 residues are phosphorylated, but not either one alone (PMID 24703952). The sequence surrounding the phosphorylation sites is 100% conserved among human, mouse, rat, equine, bovine species. Due to the large target protein size (~450 kDa), low percentage gels, such as 3% agarose or 6% polyacrylamide, are recommended to facilitate electrophoresis and transfer prior to Western blotting.
References
Product Information
FormatSerum
PresentationRabbit polyclonal serum with 0.09% sodium azide and 50% glycerol.
Quality LevelMQ300
Applications
ApplicationAnti-phospho-53BP1 Antibody is an antibody against phospho-53BP1 for use in Western Blotting.
Key Applications
  • Western Blotting
Application NotesWestern Blotting Analysis: A representative lot detected phospho-53BP1 (Thr1609/Ser1618) in HeLa cells synchronized in mitosis, HeLa cells expressing FH-53BP1 WT or phosphomutants were synchronized in mitosis and harvested by mitotic shake-off (Lee, D.H., et al. (2014). Mol. Cell. 54(3):512-525).
Western Blotting Analysis: A representative lot detected phospho-53BP1 (Thr1609/Ser1618) in U2OS blocked at G1/S (Orthwein, A., et al. (2014). Science. 344:189-193).
Biological Information
ImmunogenLinear peptide corresponding to human phospho-53BP1 (Thr1609/Ser1618).
EpitopePhosphorylated Thr1609 and phosphorylated Ser1618
ConcentrationPlease refer to lot specific datasheet.
HostRabbit
Species Reactivity
  • Human
Species Reactivity NoteHuman. Predicted to react with Mouse, Bovine based on 100% sequence homology.
Antibody TypePolyclonal Antibody
Entrez Gene Number
Gene Symbol
  • TP53BP1
Modifications
  • Phosphorylation
  • Phosphorylation
Purification MethodUnpurified
UniProt Number
Molecular Weight~430 kDa observed. Uncharacterized band(s) may appear in some lysates.
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality AssuranceEvaluated by Western Blotting using G1 or mitotic HeLa cell lysate.

Western Blotting Analysis: A 1:5,000 dilution of this antibody detected phospho-53BP1 (Thr1609/Ser1618) in 10 µg from mitotic, but not G1, HeLa cell lysate.
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at -20°C from date of receipt.
Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
Note: Variability in freezer temperatures below -20°C may cause glycerol containing solutions to become frozen during storage.
Packaging Information
Material Size100 µL
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Número de referencia GTIN
ABE1446 04055977164893

Documentation

Anti-phospho-53BP1 (Thr1609/Ser1618) Antibody Certificados de análisis

CargoNúmero de lote
Anti-phospho-53BP1 (Thr1609/Ser1618) - 3467023 3467023
Anti-phospho-53BP1 (Thr1609/Ser1618) - 3874311 3874311
Anti-phospho-53BP1 (Thr1609/Ser1618) -Q2564190 Q2564190

Referencias bibliográficas

Visión general referenciasPub Med ID
Mitosis inhibits DNA double-strand break repair to guard against telomere fusions.
Orthwein, A; Fradet-Turcotte, A; Noordermeer, SM; Canny, MD; Brun, CM; Strecker, J; Escribano-Diaz, C; Durocher, D
Science (New York, N.Y.)  344  189-93  2014

Mostrar resumen
24652939 24652939
Dephosphorylation enables the recruitment of 53BP1 to double-strand DNA breaks.
Lee, DH; Acharya, SS; Kwon, M; Drane, P; Guan, Y; Adelmant, G; Kalev, P; Shah, J; Pellman, D; Marto, JA; Chowdhury, D
Molecular cell  54  512-25  2014

Mostrar resumen
24703952 24703952

Folleto

Cargo
NPI Flyer- Epigenetics and Nuclear Function Feature

Licencias necesarias e Información técnica

Cargo
White Paper: Further considerations of antibody validation and usage.